Australian Clinical Trials

Clinical Trials Related to EB in Australia

The following clinical trials in EB are currently active in Australia. Anyone who is interested is encouraged to contact one of the study centres to obtain more information about the trial.

Trial Status Links for More Information
An International, Multicenter, Randomized, Double-Blind, Parallel-Group Phase 2 Study Evaluating the Safety and Efficacy of Diacerein 1% Ointment Topical Formulation in Subjects with Epidermolysis Bullosa Simplex (EBS) Recruiting

Study identifier: NCT03154333

Study Language for Patient Advocacy Website:

Read Document

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa Study closed.

Study identifier NCT02670330

Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE) Recruiting

Study identifier NCT03068780

BEB-13 Trial Information Sheet

Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study Recruiting

Study identifier NCT03016715

Sirolimus Trial Introductory Letter

Date revised: 22 March 2018